The Global Permethrin Cream Market was valued at USD 8.90 Million in 2023 and is projected to reach USD 12.24 Million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 3.60% during the forecast period (2025–2032). The North America segment was estimated at USD 2.46 Million in 2023, with a CAGR of 3.09% during the same period. This growth is propelled by the high prevalence of scabies and lice infestations, rising public health awareness, and the product’s established efficacy as a first-line topical parasiticide.

As public health systems and dermatological care continue to evolve, the focus turns to the key pharmaceutical manufacturers driving innovation, production, and distribution of this essential treatment. In this blog, we profile the Top 10 Companies in the Permethrin Cream Industry—a mix of established pharma giants, generic drug leaders, and specialized dermatology firms shaping global access to scabicidal therapy.

---

🔟 1. GlaxoSmithKline plc (GSK)

Headquarters: Brentford, London, UK
Key Offering: Nix® Lice Treatment Cream Rinse (Permethrin 1%)

GSK, through its iconic over-the-counter (OTC) brand Nix, is a dominant global player in permethrin-based lice treatment. Nix is one of the most recognized consumer brands for head lice and is widely available in pharmacies across North America and Europe, benefiting from GSK’s vast consumer healthcare distribution network.

Key Market Initiatives:

• Strong consumer marketing and brand recognition for head lice treatment.
• Continuous OTC portfolio investment in dermatological conditions.
• Focus on accessible, pharmacy-first solutions for parasitic infestations.

Download FREE Sample Report:
Permethrin Cream Market – View in Detailed Research Report

---

9️⃣ 2. Perrigo Company plc

Headquarters: Dublin, Ireland (Operational HQ in Michigan, USA)
Key Offering: Store-brand (Private Label) Permethrin Cream & Lotion, Nix®-comparable products

As the world’s largest manufacturer of OTC healthcare products and a leading provider of store-brand pharmaceuticals, Perrigo is a powerhouse in the generic permethrin cream market. It supplies major retail chains, pharmacy groups, and distributors with high-quality, affordable generic versions, significantly driving market volume.

Key Market Initiatives:

• Extensive private-label manufacturing for major retailers (CVS, Walgreens, Walmart).
• Strategic focus on expanding its topical generics portfolio.
• Ensuring supply chain robustness for essential medicines.

---

8️⃣ 3. Padagis

Headquarters: Minneapolis, Minnesota, USA
Key Offering: Permethrin Cream, 5% (Elimite® generic), Permethrin Lotion, 1%

Padagis (formed from the merger of Perrigo’s US prescription business and a portfolio from Alvogen) is a prominent US-based specialty generic company. It is a key supplier of prescription-strength permethrin cream 5%, used for scabies, ensuring reliable access to this clinically important treatment.

Key Market Initiatives:

• Leading supplier of generic Elimite® (permethrin 5% cream) in the U.S. market.
• Focus on complex generics and dermatology-focused products.
• Commitment to addressing drug shortages for essential topical medications.

---

7️⃣ 4. Teva Pharmaceutical Industries Ltd.

Headquarters: Tel Aviv, Israel
Key Offering: Generic Permethrin Cream 5%

Teva, a global leader in generic medicines, is a significant manufacturer and distributor of permethrin cream. Its extensive global supply chain ensures the availability of affordable generic permethrin in numerous markets, supporting public health initiatives in both developed and developing regions.

Key Market Initiatives:

• Global distribution network for cost-effective generic pharmaceuticals.
• Broad portfolio in dermatological generics and APIs.
• Active in tenders for public health programs requiring scabicides.

Download FREE Sample Report:
Permethrin Cream Market – View in Detailed Research Report

---

6️⃣ 5. Encube Ethicals Pvt. Ltd.

Headquarters: Mumbai, Maharashtra, India
Key Offering: Semi-solid formulations (Creams & Ointments) including Permethrin for global partners.

Encube Ethicals is a leading contract development and manufacturing organization (CDMO) specializing in semi-solid and topical dosage forms. It is a critical behind-the-scenes player, manufacturing permethrin cream for numerous pharmaceutical companies worldwide under their branded or private labels.

Key Market Initiatives:

• World-class topical manufacturing facilities with global regulatory approvals (USFDA, MHRA).
• Strategic partnerships with innovator and generic pharma companies.
• Focus on scaling production of essential dermatology products.

---

5️⃣ 6. Taro Pharmaceutical Industries Ltd. (a Sun Pharma subsidiary)

Headquarters: Haifa, Israel
Key Offering: Generic Permethrin Cream

Taro Pharmaceutical, part of the Sun Pharma network, is a major multinational specializing in branded and generic prescription dermatology products. It manufactures and markets permethrin cream, leveraging its strong dermatology commercial infrastructure, particularly in North America.

Key Market Initiatives:

• Strong presence in the dermatology therapeutic area.
• Integrated R&D and manufacturing for topical products.
• Extensive portfolio of generic and branded topical creams and ointments.

---

4️⃣ 7. Torrent Pharmaceuticals Ltd.

Headquarters: Ahmedabad, Gujarat, India
Key Offering: Permethrin Cream and other dermatological generics for domestic and international markets.

Torrent Pharma is a key force in the Indian pharmaceutical market with a growing global footprint. It manufactures permethrin cream for the domestic market and exports to various regions, contributing to affordable access in price-sensitive markets.

Key Market Initiatives:

• Significant market share in the Indian dermatology segment.
• Expanding international operations in semi-regulated and emerging markets.
• Focus on a robust pipeline of dermatology and cardiology products.

---

3️⃣ 8. Zeelab Pharmacy Pvt. Ltd.

Headquarters: Baddi, Himachal Pradesh, India
Key Offering: Permethrin Cream and a wide range of generic topical formulations.

Zeelab Pharmacy is an emerging Indian pharmaceutical company with a dedicated focus on manufacturing quality generic drugs. It is an active supplier of permethrin cream within the Indian subcontinent and other select export markets, emphasizing cost-effectiveness.

Key Market Initiatives:

• Growing manufacturing capabilities for topical dosage forms.
• Focus on serving the domestic Indian and neighboring market demands.
• Commitment to WHO-GMP and other quality standards.

---

2️⃣ 9. Fougera Pharmaceuticals Inc. (a division of Sandoz/Novartis)

Headquarters: Melville, New York, USA
Key Offering: Generic Permethrin Cream 5% (Elimite® equivalent).

Fougera, now part of Sandoz (a Novartis division), is a historic leader in generic dermatologicals in the United States. It has been a longstanding, trusted supplier of generic topical products, including permethrin cream, to the U.S. healthcare system.

Key Market Initiatives:

• Long-standing heritage and trust in the U.S. generic dermatology market.
• Strong distribution network to hospitals, clinics, and pharmacies.
• Portfolio focused on a wide array of generic creams and ointments.

---

1️⃣ 10. Sun Pharmaceutical Industries Ltd.

Headquarters: Mumbai, Maharashtra, India
Key Offering: Permethrin Cream through its subsidiaries and extensive generic portfolio.

As India’s largest pharmaceutical company and a top global specialty generic player, Sun Pharma exerts significant influence on the market. Through its own operations and subsidiaries like Taro, it ensures a wide global supply of permethrin cream, particularly in emerging economies where disease burden is high.

Key Market Initiatives:

• Global scale and supply chain for essential generic medicines.
• Strong R&D and manufacturing prowess in dermatology.
• Strategic focus on expanding in high-growth emerging markets.

Read Full Report:
Permethrin Cream Market – View in Detailed Research Report

---

🏥 Outlook: The Future of Permethrin Cream Relies on Access and Adherence

The permethrin cream market is characterized by steady demand driven by endemic parasitic infections. While generics dominate, the future hinges on ensuring consistent supply, combating resistance concerns, and improving treatment access in underserved regions.

📈 Key Trends Shaping the Market:

• Increasing incidence of scabies outbreaks in institutional and community settings globally.
• Growing preference for OTC solutions for head lice, boosting retail sales.
• Public health programs in developing nations procuring generics in bulk.
• Consolidation among generic manufacturers and CDMOs to optimize production.

Read Full Report:
Permethrin Cream Market – View in Detailed Research Report

The companies listed above are not only supplying a critical treatment—they are underpinning public health responses to neglected tropical diseases and common parasitic infestations worldwide.